Ketogenic Diet May Outperform Low-Fat Diet for Type 2 Diabetes Remission

How Does a Ketogenic Diet Help Reverse Type 2 Diabetes?

Type 2 diabetes is fundamentally a disease of carbohydrate intolerance and insulin resistance. When carbohydrate intake is reduced to roughly 20 to 50 grams per day, blood glucose excursions after meals diminish substantially, and the pancreas is required to release far less insulin. Over weeks to months, this reduced demand on the beta cells appears to allow some recovery of insulin sensitivity in peripheral tissues such as muscle and liver.

Research from groups including Virta Health, led by Dr. Sarah Hallberg before her death, has shown that sustained nutritional ketosis can produce clinically meaningful reductions in HbA1c and allow many participants to discontinue insulin and sulfonylureas. The American Diabetes Association now recognizes low-carbohydrate eating patterns as one of several evidence-based options in its Standards of Care, though it stops short of endorsing ketogenic diets as first-line therapy for everyone.

What Did the Comparison With Low-Fat Diets Show?

Head-to-head trials, including work published in journals such as Diabetes Therapy and Annals of Internal Medicine, have generally found that very low-carbohydrate diets outperform low-fat, calorie-restricted diets at 6 and 12 months for outcomes including HbA1c reduction, body weight, and triglycerides. The Medical News Today coverage referenced in this report highlights a recent comparative analysis suggesting that the ketogenic approach was associated with higher rates of diabetes remission, defined as HbA1c below 6.5% without glucose-lowering medication.

However, clinicians emphasize important caveats. LDL cholesterol can rise in a subset of individuals on ketogenic diets, requiring lipid monitoring. Adherence is challenging long term, and benefits often attenuate when participants drift back toward higher-carbohydrate intake. Patients on insulin or SGLT2 inhibitors require close supervision when starting low-carb regimens because of hypoglycemia and euglycemic ketoacidosis risk.

Who Should Consider a Ketogenic Approach?

Ideal candidates typically include motivated patients with relatively recent-onset type 2 diabetes, preserved beta-cell function, and access to a clinician comfortable adjusting medications as glucose values fall. Patients with longer disease duration or significant insulin requirements can still benefit but require more careful titration of therapy.

Contraindications and cautions include pregnancy, a history of pancreatitis, certain rare genetic disorders of fat metabolism, and advanced kidney disease. The Academy of Nutrition and Dietetics recommends individualized counseling and regular follow-up for anyone undertaking a substantial dietary change for diabetes management, and stresses that no single diet is universally superior — patient preference, cultural context, and sustainability all matter.